Patent · US Active

Compounds

US7977344B2 · kind B2 · utility

14Cited by
5References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2008
Grant dateJul 12, 2011
Priority date
Expiry dateOct 16, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes novel compounds useful in the treatment of various disorders in particular infectious diseases, cancer, and allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, and as vaccine adjuvants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.